The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Recent progress in pancreatic cancer
Open accessAbstract
Answer questions and earn CME/CNE Pancreatic cancer is currently one of the deadliest of the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and less invasive than ever, novel drug combinations have been shown to improve survival, advances in radiation therapy have resulted in less toxicity, and enormous strides have been made in the understanding of the fundamental genetics of pancreatic cancer. These advances provide hope but they also increase the complexity of caring for patients. It is clear that multidisciplinary care that provides comprehensive and coordinated evaluation and treatment is the most effective way to manage patients with pancreatic cancer. CA Cancer J Clin 2013;63:318‐348. © 2013 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–206 of 206
Boyd, A. D., Brown, D. R., Henrickson, C., Hampton, J., Zhu, B., Almani, F., Ben‐Josef, E., Zalupski, M. M., Simeone, D. M., Taylor, J. M. G., et al. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/650707 · Cited by 33
Familial pancreatic cancer in South Louisiana
Price, T. F., Payne, R. L., & Oberleitner, M. G. (1996) · Cancer Nursing · doi:10.1097/00002820-199608000-00003 · Cited by 28
(2013) · Gut · doi:10.1136/gutjnl-2012-303108corr1 · Cited by 25
Management of Familial Melanoma and Nonmelanoma Skin Cancer Syndromes
Santillan, A. A., Cherpelis, B. S., Glass, L. F., & Sondak, V. K. (2008) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2008.08.003 · Cited by 18
Clinical impact of radiotherapy for locally advanced pancreatic cancer
Sawaki, A., Hoki, N., Ito, S., Matsumoto, K., Mizuno, N., Hara, K., Takagi, T. J., Kobayashi, Y., Sawai, Y., Kawai, H., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0116-9 · Cited by 10
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1098-1004(1998)12:1 · Cited by 1
Cited by
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.007 · Cited by 2,019
“Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease that typically presents at an advanced stage and is refractory to most treatment modalities (Ryan et al., 2014; Wolfgang et al., 2013).”
Self-citationKleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Self-citationKRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
Waters, A. M., & Der, C. J. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031435 · Cited by 875
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience
Kamada, T., Tsujii, H., Blakely, E. A., Debus, J., De Neve, W., Durante, M., Jäkel, O., Mayer, R., Orecchia, R., Pötter, R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70412-7 · Cited by 562
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
Gemenetzis, G., Groot, V. P., Blair, A. B., Laheru, D. A., Zheng, L., Narang, A. K., Fishman, E. K., Hruban, R. H., Yu, J., Burkhart, R. A., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000002753 · Cited by 401
Self-citation
Metadata
- Authors
- Wolfgang, C. L., Herman, J. M., Laheru, D. A., Klein, A. P., Erdek, M. A., Fishman, E. K., & Hruban, R. H.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2013-07-15
- Volume
- 63
- Issue
- 5
- Pages
- 318-348
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2160391606
- Cited by
- 910
- References
- 206
- FWCI
- 32.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.